Trial Information

Summary: Irritable Bowel Syndrome (IBS) Study in San Francisco Now Enrolling.

The purpose of this study is to evaluate different dosages of an investigational medication for treating severe diarrhea in Irritable Bowel Syndrome (IBS).

Dean L. Rider will conduct the study. Dr. Rider had been practicing gastroenterology in San Francisco for over twenty years.

You may be qualified to participate in the study if you:

• Are a woman.
• Are at least 18 years old.
• Reside in or around San Francisco.
• Have had severe diarrhea as a predominant symptoms of (IBS) symptoms for at least six months.
• Have failed conventional therapy.

Study Profile:

• The study will include 8 visits over 19 weeks.
• You will receive all study-related medications, exams and lab tests at no cost.
• There is no charge for participating in the study.
• You will receive compensation for your time and travel expenses.
• Office visits will be conducted at 350 Parnassus Avenue in San Francisco near UCSF Medical Center.

If you would like to learn more about this study,

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:43:56 AM